Latest News

First trial to investigate magic mushrooms as a treatment for depression delayed by UK and EU regulations

The world?s first clinical trial to explore the use of the hallucinogenic ingredient in magic mushrooms to treat depression is being delayed due to the UK and EU rules on the use of illegal drugs in research.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Novel DNA repair mechanism brings new horizons

  • REM sleep critical for young brain development; medication interferes

  • How the stress hormone cortisol reinforces traumatic memories

  • Documenting how dementia sufferers benefit from GPS

  • Prion trials and tribulations: Finding the right tools and experimental models

  • Puccini?s ?exotic inspiration?:Unusual source of Madam Butterfly's melodies revealed

  • Online reader comments can provide valuable feedback to news sites

  • Pinpointing mutations in a relapsed children's cancer may lead to improved treatments

  • Infection with Wolbachia bacteria curbs fighting among fruit flies

  • Rapid response to kids' stroke symptoms may speed diagnosis

  •